150 related articles for article (PubMed ID: 37356802)
1. European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database.
Opitz I; Bille A; Dafni U; Nackaerts K; Ampollini L; de Perrot M; Brcic L; Nadal E; Syrigos K; Gray SG; Aerts J; Curioni-Fontecedro A; Rüschoff JH; Monkhorst K; Weynand B; Silini EM; Bavaghar-Zaeimi F; Jakopovic M; Llatjos R; Tsimpoukis S; Finn SP; von der Thüsen J; Marti N; Dimopoulou G; Kammler R; Peters S; Stahel RA; Falcoz PE; Brunelli A; Baas P;
J Thorac Oncol; 2023 Sep; 18(9):1233-1247. PubMed ID: 37356802
[TBL] [Abstract][Full Text] [Related]
2. Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project.
Rüschoff JH; Haberecker M; Tsourti Z; Nackaerts K; de Perrot M; Brcic L; Nadal E; Tsimpoukis S; Gray SG; Ampollini L; Aerts JG; Felley-Bosco E; Kirschner MB; Monkhorst K; Weynand B; Bavaghar-Zaeimi F; Samarzija M; Llatjos R; Finn SP; Silini E; von der Thüsen J; Marti N; Vervita K; Kammler R; Peters S; Stahel RA; Baas P; Opitz I;
Mod Pathol; 2022 Dec; 35(12):1888-1899. PubMed ID: 36115922
[TBL] [Abstract][Full Text] [Related]
3. Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma.
Alnajar A; Kareff SA; Razi SS; Rao JS; De Lima Lopes G; Nguyen DM; Villamizar N; Rodriguez E
JAMA Netw Open; 2023 Mar; 6(3):e234261. PubMed ID: 36951862
[TBL] [Abstract][Full Text] [Related]
4. Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan.
Hasegawa S; Shintani Y; Takuwa T; Aoe K; Kato K; Fujimoto N; Hida Y; Morise M; Moriya Y; Morohoshi T; Suzuki H; Chida M; Endo S; Kadokura M; Okumura M; Hattori S; Date H; Yoshino I
Cancer Sci; 2024 Feb; 115(2):507-528. PubMed ID: 38047872
[TBL] [Abstract][Full Text] [Related]
5. Management of database: European Society of Thoracic Surgeons mesothelioma database-difficulties in improving quality data for rare tumour.
Bille A
J Thorac Dis; 2018 Oct; 10(Suppl 29):S3486-S3489. PubMed ID: 30510783
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological, therapeutic, and survival trends in malignant pleural mesothelioma: A review of the National Cancer Database.
Bou-Samra P; Chang A; Azari F; Kennedy G; Segil A; Guo E; Marmarelis M; Langer C; Singhal S
Cancer Med; 2023 Jun; 12(11):12208-12220. PubMed ID: 37062067
[TBL] [Abstract][Full Text] [Related]
7. Multimodality Therapy in Patients With Primary Pericardial Mesothelioma.
Offin M; De Silva DL; Sauter JL; Egger JV; Yorke E; Adusumilli PS; Rimner A; Rusch VW; Zauderer MG
J Thorac Oncol; 2022 Dec; 17(12):1428-1432. PubMed ID: 36075530
[TBL] [Abstract][Full Text] [Related]
8. Malignant pleural mesothelioma characteristics and outcomes: A SEER-Medicare analysis.
Taioli E; Wolf A; Alpert N; Rosenthal D; Flores R
J Surg Oncol; 2023 Jul; 128(1):134-141. PubMed ID: 36932968
[TBL] [Abstract][Full Text] [Related]
9. Contemporary issues in the surgical management of pleural mesothelioma.
Paajanen J; Jaklitsch MT; Bueno R
J Surg Oncol; 2023 Feb; 127(2):343-354. PubMed ID: 36630097
[TBL] [Abstract][Full Text] [Related]
10. Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival.
Verma V; Ahern CA; Berlind CG; Lindsay WD; Shabason J; Sharma S; Culligan MJ; Grover S; Friedberg JS; Simone CB
Clin Lung Cancer; 2018 Nov; 19(6):e901-e912. PubMed ID: 30224273
[TBL] [Abstract][Full Text] [Related]
11. Management of malignant pleural mesothelioma - part 3 : Data from the Austrian Mesothelioma Interest Group (AMIG) database.
Klikovits T; Hoda MA; Dong Y; Arns M; Baumgartner B; Errhalt P; Geltner C; Machan B; Pohl W; Hutter J; Eckmayr J; Studnicka M; Flicker M; Cerkl P; Kirchbacher K; Klepetko W
Wien Klin Wochenschr; 2016 Sep; 128(17-18):627-34. PubMed ID: 27457873
[TBL] [Abstract][Full Text] [Related]
12. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
Opitz I; Scherpereel A; Berghmans T; Psallidas I; Glatzer M; Rigau D; Astoul P; Bölükbas S; Boyd J; Coolen J; De Bondt C; De Ruysscher D; Durieux V; Faivre-Finn C; Fennell DA; Galateau-Salle F; Greillier L; Hoda MA; Klepetko W; Lacourt A; McElnay P; Maskell NA; Mutti L; Pairon JC; Van Schil P; van Meerbeeck JP; Waller D; Weder W; Putora PM; Cardillo G
Eur J Cardiothorac Surg; 2020 Jul; 58(1):1-24. PubMed ID: 32448904
[TBL] [Abstract][Full Text] [Related]
13. Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.
Baas P; Daumont MJ; Lacoin L; Penrod JR; Carroll R; Venkatesan S; Ubhi H; Calleja A; Snee M
Lung Cancer; 2021 Dec; 162():185-193. PubMed ID: 34823894
[TBL] [Abstract][Full Text] [Related]
14. Ki67 Tumor Expression Predicts Treatment Benefit Achieved by Macroscopic Radical Lung-Preserving Surgery in Pleural Mesothelioma-A Retrospective Multicenter Analysis.
Hintermair S; Iser S; Varga A; Biesinger M; Bohanes T; Celik A; Sayan M; Kankoç A; Akyurek N; Öğüt B; Stubenberger E; Ghanim B
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791896
[TBL] [Abstract][Full Text] [Related]
15. Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: the outcome of incomplete resections.
Bölükbas S; Eberlein M; Fisseler-Eckhoff A; Schirren J
Lung Cancer; 2013 Aug; 81(2):241-6. PubMed ID: 23688589
[TBL] [Abstract][Full Text] [Related]
16. The 2019 ERS/ESTS/EACTS/ESTRO Guidelines on the Management of Patients With Malignant Pleural Mesothelioma.
Gelzinis TA
J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):378-388. PubMed ID: 32798169
[TBL] [Abstract][Full Text] [Related]
17. Multimodal Treatment of Pleural Mesothelioma with Cytoreductive Surgery and Hyperthermic Intrathoracic Chemotherapy: Impact of Additive Chemotherapy.
Klotz LV; Zimmermann J; Müller K; Kovács J; Hassan M; Koller M; Schmid S; Huppertz G; Markowiak T; Passlick B; Hofmann HS; Winter H; Hatz RA; Eichhorn ME; Ried M
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672669
[TBL] [Abstract][Full Text] [Related]
18. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma.
Scherpereel A; Opitz I; Berghmans T; Psallidas I; Glatzer M; Rigau D; Astoul P; Bölükbas S; Boyd J; Coolen J; De Bondt C; De Ruysscher D; Durieux V; Faivre-Finn C; Fennell D; Galateau-Salle F; Greillier L; Hoda MA; Klepetko W; Lacourt A; McElnay P; Maskell NA; Mutti L; Pairon JC; Van Schil P; van Meerbeeck JP; Waller D; Weder W; Cardillo G; Putora PM
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32451346
[TBL] [Abstract][Full Text] [Related]
19. Persistent lung expansion after pleural talc poudrage in non-surgically resected malignant pleural mesothelioma.
Rena O; Boldorini R; Papalia E; Mezzapelle R; Baietto G; Roncon A; Casadio C
Ann Thorac Surg; 2015 Apr; 99(4):1177-83. PubMed ID: 25669666
[TBL] [Abstract][Full Text] [Related]
20. Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma.
Kadota K; Suzuki K; Sima CS; Rusch VW; Adusumilli PS; Travis WD
J Thorac Oncol; 2011 May; 6(5):896-904. PubMed ID: 21358344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
